<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Open Access pages ( https://us.sagepub.com/en-us/nam/open-access-at-sage). Abstract A continuous challenge in" exact="cancer" post="management is to improve treatment efficacy and to diminish"/>
 <result pre="cells and animal models, as well as its role in" exact="cancer" post="palliative care. A systematic review of studies describing the"/>
 <result pre="cytotoxic role of C officinalis and its therapeutic role on" exact="cancer" post="cells were carried out using the PubMed database. Albeit"/>
 <result pre="database. Albeit C officinalis extracts have cytotoxic activity toward different" exact="cancer" post="cell lines, a high grade of variation between studies"/>
 <result pre="on plant organ subjected to extraction, extraction method, and the" exact="cancer" post="cell lines used for each study. Nevertheless, its cytotoxic"/>
 <result pre="C officinalis could have important future implications in developing novel" exact="cancer" post="treatment strategies, while until now it has been used"/>
 <result pre="used especially for diminishing the side effects of radiotherapy. Calendula" exact="cancer" post="cytotoxicity genoprotective antimetastatic palliative care Funding Autoritatea Natională pentru"/>
 <result pre="about 70% over the next 2 decades. 1 Depending on" exact="cancer" post="stage, its phenotype, and localization, the ongoing treatment options"/>
 <result pre="in early stages, chemotherapy represents the most important choice of" exact="cancer" post="armamentarium for advanced cancers as well as hematological malignancies."/>
 <result pre="chemotherapy represents one of the most important approaches to kill" exact="cancer" post="cells, it produces many side effects by damaging healthy"/>
 <result pre="are associated with adjuvant chemotherapy. 2 Another major problem in" exact="cancer" post="treatment is that tumor cells become resistant to radiochemotherapy,"/>
 <result pre="known as baseline resistance and recorded in about 50% of" exact="cancer" post="patients or by acquiring resistance over time, as a"/>
 <result pre="effects, immunotherapy, including monoclonal antibodies, adoptive cell transfer, cytokines, and" exact="cancer" post="vaccines, represents a reliable targeted therapy. However, it is"/>
 <result pre="and compounds are constantly developed in an effort to improve" exact="cancer" post="therapy and to diminish treatment side effects. In this"/>
 <result pre="important research fields aiming to identify new compounds useful for" exact="cancer" post="treatment is that related to plants. Plants have been"/>
 <result pre="to identify novel plant compounds as possible effective drugs in" exact="cancer" post="treatment. Bioactive agents originating from plants like Catharanthus roseus,"/>
 <result pre="widely used nowadays in the treatment of different types of" exact="cancer" post="and part of the World Health Organization’s List of"/>
 <result pre="medicine (CAM). CAM are used by around 49% of all" exact="cancer" post="patients after the year 2000, 10 herbal medicine being"/>
 <result pre="pot marigold, shows promising results regarding its potential use in" exact="cancer" post="management. In this article, we review the latest updates"/>
 <result pre="constituents that present cytotoxic activity, thereby its potential usage in" exact="cancer" post="treatment and CAM. Furthermore, we emphasize its putative role"/>
 <result pre="25 With the expansion of CAM based on herbs as" exact="cancer" post="treatment, 10 the interest in the putative anticancer efficacy"/>
 <result pre="C officinalis extracts were identified as possessing significant cytotoxicity toward" exact="cancer" post="cell lines in vitro. Lutein, isolated through silica gel"/>
 <result pre="magnetic resonance, was found to possess selective cytotoxic activity toward" exact="breast cancer" post="cell lines. 27 The ¼ IC 50 value was"/>
 <result pre="resonance, was found to possess selective cytotoxic activity toward breast" exact="cancer" post="cell lines. 27 The ¼ IC 50 value was"/>
 <result pre="suggesting that lutein has a greater cytotoxic activity toward triple-negative" exact="breast cancer" post="rather than luminal breast cancer. Furthermore, significantly lower doses"/>
 <result pre="that lutein has a greater cytotoxic activity toward triple-negative breast" exact="cancer" post="rather than luminal breast cancer. Furthermore, significantly lower doses"/>
 <result pre="greater cytotoxic activity toward triple-negative breast cancer rather than luminal" exact="breast cancer." post="Furthermore, significantly lower doses of lutein were cytotoxic toward"/>
 <result pre="cancer. Furthermore, significantly lower doses of lutein were cytotoxic toward" exact="breast cancer" post="cell lines, when compared with its activity against the"/>
 <result pre="Furthermore, significantly lower doses of lutein were cytotoxic toward breast" exact="cancer" post="cell lines, when compared with its activity against the"/>
 <result pre="proteins like p53, bax, and caspase-3 were increased in lutein-treated" exact="cancer" post="cells (except caspase-3 in MCF7, where the protein was"/>
 <result pre="activity in 60 cell lines derived from leukemia, non–small cell" exact="lung cancer," post="colon cancer, central nervous system cancer, melanoma, ovarian cancer,"/>
 <result pre="60 cell lines derived from leukemia, non–small cell lung cancer," exact="colon cancer," post="central nervous system cancer, melanoma, ovarian cancer, renal cancer,"/>
 <result pre="lines derived from leukemia, non–small cell lung cancer, colon cancer," exact="central nervous system cancer," post="melanoma, ovarian cancer, renal cancer, prostate cancer, and breast"/>
 <result pre="cell lung cancer, colon cancer, central nervous system cancer, melanoma," exact="ovarian cancer," post="renal cancer, prostate cancer, and breast cancer. At 48"/>
 <result pre="cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer," exact="prostate cancer," post="and breast cancer. At 48 hours after treatment, the"/>
 <result pre="system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer, and" exact="breast cancer." post="At 48 hours after treatment, the IC 50 values"/>
 <result pre="demonstrated that C officinalis extracts have cytotoxic activity toward different" exact="cancer" post="cell lines, but the half maximal inhibitory concentration (IC"/>
 <result pre="and method, the plant organs subjected for extraction, and the" exact="cancer" post="cell line used for each study. C officinalis flowers/flos"/>
 <result pre="selective cytotoxicity of C officinalis flower extract against 5 different" exact="cancer" post="cell lines (HeLa, Fem-X, MDA-MB-361, LS174, and K562) in"/>
 <result pre="The IC 50 value after a 24-hour treatment for the" exact="cancer" post="cell lines varied between 360 µg/mL for the FemX"/>
 <result pre="context, the pot marigold extract proved to be selective against" exact="cancer" post="cell lines when compared with PBMCs, the selectivity coefficient"/>
 <result pre="effects of the LACE extract were determined on 12 different" exact="cancer" post="cell lines and also on human peripheral blood lymphocytes"/>
 <result pre="70% to 100% for all tested cell lines, except the" exact="leukemia" post="cell line U937. LACE was found producing significantly higher"/>
 <result pre="to 144-hour treatment with 250-µg/mL LACE, cells belonging to several" exact="cancer" post="cell lines accumulated in the G0/G1 phase, suggesting a"/>
 <result pre="extract. In contrast with the cytotoxic activity of LACE on" exact="cancer" post="cell lines, the extract proved to significantly increase the"/>
 <result pre="values measured at 72 hours after treatment on 4 different" exact="cancer" post="cell lines (HL-60, HCT-8, B16, and MCF7) varied between"/>
 <result pre="50.5 and 83.9 µg/mL, with the highest cytotoxicity against murine" exact="skin melanoma" post="(B16 cell line) and the lowest against breast cancer"/>
 <result pre="murine skin melanoma (B16 cell line) and the lowest against" exact="breast cancer" post="(MCF7 cell line). When the concentration was increased to125"/>
 <result pre="skin melanoma (B16 cell line) and the lowest against breast" exact="cancer" post="(MCF7 cell line). When the concentration was increased to125"/>
 <result pre="on the in vitro success of LACE extract on different" exact="cancer" post="cell lines, Jimenez-Medina et al 31 also investigated the"/>
 <result pre="in vitro and in vivo models, its use in human" exact="cancer" post="management is generally limited to the treatment of the"/>
 <result pre="effects induced by radiochemotherapy. Palliative care, an important part of" exact="cancer" post="management nowadays, is focused on improving the quality of"/>
 <result pre="nowadays, is focused on improving the quality of life in" exact="cancer" post="patients by treating the symptoms and side effects of"/>
 <result pre="disease and its treatment. With this purpose, more and more" exact="cancer" post="patients are using CAM, including herbal remedies, 10 even"/>
 <result pre="the side effects of radiotherapy in breast, head, and neck" exact="cancer" post="patients. In a simple-blinded phase III randomized clinical trial"/>
 <result pre="In a simple-blinded phase III randomized clinical trial including 254" exact="breast cancer" post="patients, the liposoluble fraction of C officinalis extracted in"/>
 <result pre="a simple-blinded phase III randomized clinical trial including 254 breast" exact="cancer" post="patients, the liposoluble fraction of C officinalis extracted in"/>
 <result pre="evaluated about its putative role in prevention of acute radiation-induced" exact="dermatitis" post="of grade 2 or higher. The prevention capacity was"/>
 <result pre="topical agent often prescribed during radiotherapy as part of the" exact="breast cancer" post="palliative care. The incidence of grade 2 or 3"/>
 <result pre="agent often prescribed during radiotherapy as part of the breast" exact="cancer" post="palliative care. The incidence of grade 2 or 3"/>
 <result pre="be a good nonsteroid agent for the prevention of radiation-induced" exact="dermatitis" post="in breast cancer patients. 38 Albeit the effectiveness of"/>
 <result pre="good nonsteroid agent for the prevention of radiation-induced dermatitis in" exact="breast cancer" post="patients. 38 Albeit the effectiveness of Calendula was better"/>
 <result pre="nonsteroid agent for the prevention of radiation-induced dermatitis in breast" exact="cancer" post="patients. 38 Albeit the effectiveness of Calendula was better"/>
 <result pre="to be ineffective in the prevention and treatment of radiation" exact="dermatitis" post="40 ; thus, its usage as a control in"/>
 <result pre="(Essex-Schering-Plough), in prevention of acute radiation skin reaction (ARSR) in" exact="breast cancer" post="patients. The incidence of severe ARSR was similar in"/>
 <result pre="in prevention of acute radiation skin reaction (ARSR) in breast" exact="cancer" post="patients. The incidence of severe ARSR was similar in"/>
 <result pre="of radiotherapy, but it occurs more often in patients with" exact="head and neck cancer," post="due to the area of the treatment field. A"/>
 <result pre="A randomized double-blind controlled clinical trial was conducted on 51" exact="head and neck cancer" post="patients to evaluate the effectiveness of C officinalis in"/>
 <result pre="controlled clinical trial was conducted on 51 head and neck" exact="cancer" post="patients to evaluate the effectiveness of C officinalis in"/>
 <result pre="essential fatty acids (EFA), an often recommended palliative therapy in" exact="head and neck cancer" post="patients. Each product was applied on the skin, twice"/>
 <result pre="(EFA), an often recommended palliative therapy in head and neck" exact="cancer" post="patients. Each product was applied on the skin, twice"/>
 <result pre="radiodermatitis, after 15 treatment sessions, the incidence of grade 1" exact="dermatitis" post="being 40.73% for the EFA group and only 25%"/>
 <result pre="care option than EFA treatment for the prevention of radiation-induced" exact="dermatitis" post="in head and neck cancer patients, it has to"/>
 <result pre="than EFA treatment for the prevention of radiation-induced dermatitis in" exact="head and neck cancer" post="patients, it has to be mentioned that only 27"/>
 <result pre="for the prevention of radiation-induced dermatitis in head and neck" exact="cancer" post="patients, it has to be mentioned that only 27"/>
 <result pre="In this context, a placebo-controlled clinical trial conducted on 40" exact="head and neck cancer" post="patients proved that C officinalis flower extract mouthwash significantly"/>
 <result pre="a placebo-controlled clinical trial conducted on 40 head and neck" exact="cancer" post="patients proved that C officinalis flower extract mouthwash significantly"/>
 <result pre="is already stated that Calendula could be considered for human" exact="cancer" post="management, especially for the treatment of the secondary effects"/>
 <result pre="will certainly establish the efficiency and usefulness of Calendula in" exact="cancer" post="management. Conclusions, Challenges, and Perspectives Calendula officinalis extracts and"/>
 <result pre="extracts and isolated compounds have revealed a reliable potential in" exact="cancer" post="management, both in treatment and in palliative care. Several"/>
 <result pre="present significant in vitro selective cytotoxicity toward large panels of" exact="cancer" post="cell lines when compared with healthy cells. The cytotoxic"/>
 <result pre="lines when compared with healthy cells. The cytotoxic activity against" exact="cancer" post="cell lines reported for different C officinalis extracts varies"/>
 <result pre="33 suggested that root extracts might possess higher cytotoxicity toward" exact="cancer" post="cell lines. Accordingly, even if no study presented data"/>
 <result pre="of C officinalis flowers did not have selective cytotoxicity toward" exact="cancer" post="cell lines when compared with HSFs, while the ethyl"/>
 <result pre="flowers also proved to possess selective cytotoxic activity against different" exact="cancer" post="cell lines when compared with healthy PBMCs. 30 Furthermore,"/>
 <result pre="than extraction in methanol, even though the cytotoxic activity against" exact="cancer" post="cell lines is lower for the aqueous extracts. However,"/>
 <result pre="in C officinalis extracts to possess cytotoxic activity against different" exact="cancer" post="cell lines. However, there is a high possibility for"/>
 <result pre="antitumor agents. Lutein was found to have selective cytotoxicity toward" exact="breast cancer" post="cell lines, by inducing apoptosis in these cells. 27"/>
 <result pre="agents. Lutein was found to have selective cytotoxicity toward breast" exact="cancer" post="cell lines, by inducing apoptosis in these cells. 27"/>
 <result pre="were identified as highly cytotoxic against a large panel of" exact="cancer" post="cell lines in vitro. 28 According to the US"/>
 <result pre="screening program, for a compound to be considered cytotoxic toward" exact="cancer" post="cell lines, the IC 50 values have to be"/>
 <result pre="of radiotherapy. Two phase III randomized clinical trials, totalizing 674" exact="breast cancer" post="patients, tested the effectiveness of Calendula extracts in the"/>
 <result pre="radiotherapy. Two phase III randomized clinical trials, totalizing 674 breast" exact="cancer" post="patients, tested the effectiveness of Calendula extracts in the"/>
 <result pre="be good alternatives to the topical palliative treatments of radiation-induced" exact="dermatitis" post="in breast cancer patients, but further investigations regarding their"/>
 <result pre="alternatives to the topical palliative treatments of radiation-induced dermatitis in" exact="breast cancer" post="patients, but further investigations regarding their efficacy are necessary."/>
 <result pre="to the topical palliative treatments of radiation-induced dermatitis in breast" exact="cancer" post="patients, but further investigations regarding their efficacy are necessary."/>
 <result pre="treatment of radiodermatitis 42 and of radiation-induced OM 44 in" exact="head and neck cancer" post="patients. The first extract showed better results in preventing"/>
 <result pre="42 and of radiation-induced OM 44 in head and neck" exact="cancer" post="patients. The first extract showed better results in preventing"/>
 <result pre="cancer patients. The first extract showed better results in preventing" exact="dermatitis" post="than the EFA treatment. 42 However, there are no"/>
 <result pre="Calendula officinalis shows promising results regarding its potential usage in" exact="cancer" post="management, especially in cancer prevention, treatment, and in palliative"/>
 <result pre="results regarding its potential usage in cancer management, especially in" exact="cancer" post="prevention, treatment, and in palliative care. However, without knowing"/>
 <result pre="novel C officinalis constituents, which might become relevant resources in" exact="cancer" post="management. Declaration of Conflicting Interests: The author(s) declared no"/>
 <result pre="J Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in" exact="breast cancer" post=". Ann Oncol. 2011; 22: 1939- 1947. 21289366 3"/>
 <result pre="Piccart MJ. Long-term toxic effects of adjuvant chemotherapy in breast" exact="cancer" post=". Ann Oncol. 2011; 22: 1939- 1947. 21289366 3"/>
 <result pre="1947. 21289366 3 Luqmani YA. Mechanisms of drug resistance in" exact="cancer" post="chemotherapy . Med Princ Pract. 2005; 14( suppl 1"/>
 <result pre="166- 176. 23545045 6 Park EJ Pezzuto JM. Botanicals in" exact="cancer" post="chemoprevention. Cancer Metastasis Rev. 2002; 21: 231- 255. 12549763"/>
 <result pre="Health Organization ; 2017. 9 Weaver BA. How Taxol/paclitaxel kills" exact="cancer" post="cells. Mol Biol Cell. 2014; 25: 2677- 2681. 25213191"/>
 <result pre="Dennert G Less D Ritter E Zwahlen M. How many" exact="cancer" post="patients use complementary and alternative medicine: a systematic review"/>
 <result pre="22019489 11 Olaku O White JD. Herbal therapy use by" exact="cancer" post="patients: a literature review on case reports . Eur"/>
 <result pre="M Minciullo PL Caputi AP Gangemi S Schmidt RJ. Contact" exact="dermatitis" post="as an adverse reaction to some topically used European"/>
 <result pre="Calendula officinalis compared with trolamine for the prevention of acute" exact="dermatitis" post="during irradiation for breast cancer . J Clin Oncol"/>
 <result pre="trolamine for the prevention of acute dermatitis during irradiation for" exact="breast cancer" post=". J Clin Oncol . 2004; 22: 1447- 1453."/>
 <result pre="for the prevention of acute dermatitis during irradiation for breast" exact="cancer" post=". J Clin Oncol . 2004; 22: 1447- 1453."/>
 <result pre="al. Mucositis incidence, severity and associated outcomes in patients with" exact="head and neck cancer" post="receiving radiotherapy with or without chemotherapy: a systematic literature"/>
 <result pre="severity and associated outcomes in patients with head and neck" exact="cancer" post="receiving radiotherapy with or without chemotherapy: a systematic literature"/>
</results>
